Condition: Lobectomy · Sponsor: Tongji Hospital
Combining tegileridine PCIA with ICNB targeting peripheral nerves, may constitute an ideal analgesic model with complementary advantages. Thus potentially achieving the analgesic goal of "early pain relief, stable throughout the process, and rapid recovery," and may have a positive impact on reducing CPSP.
This description comes directly from the study's public registry record.
Aijun Xu, Dr. · 18627784217 · ajxu@tjh.tjmu.edu.cn
Hongbo Zheng, Dr. · 02783663173 · 70663307@qq.com
Always discuss trial participation with your own doctor first.
| Tongji hospital | Wuhan, Hubei, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07386626